Bioventus (BVS) Exchange Rate Effect (2020 - 2026)
Bioventus posted quarterly Exchange Rate Effect of -$608000.0 for Q1 2026, down 241.4% year-on-year from $430000.0 in Q1 2025, and down 557.14% on a QoQ basis from $133000.0 in Q4 2025.
Bioventus (BVS) has 7 years of Exchange Rate Effect data on file, last reported at -$608000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 241.4% year-over-year to -$608000.0; the trailing twelve-month figure through Mar 2026 stood at -$667000.0 (up 57.94% YoY), and the FY2025 full-year result was $371000.0, up 114.49% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$608000.0, down from $133000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$2.1 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$71000.0 (2022), against an average of -$96882.4.
- The widest annual swing landed in 2023, when Exchange Rate Effect surged 749.3%; it then plunged 660.6% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $1.1 million in 2022, then slumped by 65.02% to $368000.0 in 2023, then slumped by 660.6% to -$2.1 million in 2024, then jumped by 106.45% to $133000.0 in 2025, then tumbled by 557.14% to -$608000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$608000.0 (Q1 2026), $133000.0 (Q4 2025), and -$394000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 24.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.66 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -2.80 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.40 Mn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | -608,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -608,000.00 |
| Mar 28, 2026 | -608,000.00 |
| Dec 31, 2025 | 133,000.00 |
| Dec 31, 2025 | 133,000.00 |
| Sep 27, 2025 | -394,000.00 |
| Sep 27, 2025 | -394,000.00 |
| Jun 28, 2025 | 202,000.00 |
| Jun 28, 2025 | 202,000.00 |
| Mar 29, 2025 | 430,000.00 |
| Mar 29, 2025 | 430,000.00 |
| Dec 31, 2024 | -2.06 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Sep 28, 2024 | 466,000.00 |
| Sep 28, 2024 | 466,000.00 |
| Jun 29, 2024 | -419,000.00 |
| Jun 29, 2024 | -419,000.00 |
| Mar 30, 2024 | -544,000.00 |
| Mar 30, 2024 | -544,000.00 |
| Dec 31, 2023 | 368,000.00 |
| Dec 31, 2023 | 368,000.00 |
| Sep 30, 2023 | -440,000.00 |
| Sep 30, 2023 | -440,000.00 |
| Jul 1, 2023 | 240,000.00 |
| Jul 1, 2023 | 240,000.00 |
| Apr 1, 2023 | 461,000.00 |
| Apr 1, 2023 | 461,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Oct 1, 2022 | -238,000.00 |
| Oct 1, 2022 | -238,000.00 |
| Jul 2, 2022 | -222,000.00 |
| Jul 2, 2022 | -222,000.00 |
| Apr 2, 2022 | -71,000.00 |
| Apr 2, 2022 | -71,000.00 |
| Dec 31, 2021 | 149,000.00 |
| Dec 31, 2021 | 149,000.00 |
| Oct 2, 2021 | -206,000.00 |
| Oct 2, 2021 | -206,000.00 |
| Jul 3, 2021 | 50,000.00 |
| Jul 3, 2021 | 50,000.00 |
| Apr 3, 2021 | -221,000.00 |
| Apr 3, 2021 | -221,000.00 |
| Dec 31, 2020 | 503,000.00 |
| Dec 31, 2020 | 503,000.00 |
| Sep 26, 2020 | 272,000.00 |
| Sep 26, 2020 | 272,000.00 |
| Jun 27, 2020 | 74,000.00 |
| Jun 27, 2020 | 74,000.00 |
| Mar 28, 2020 | -260,000.00 |
| Mar 28, 2020 | -260,000.00 |